Preimplantation genetic diagnosis (PGD) is a procedure used prior to implantation to help identify genetic defects within embryos. This serves to prevent certain geneticdiseases or disorders from being passed on to the child.

Market Analysis and Insights: Global Preimplantation Genetic Diagnostics (PGD) Market
The global Preimplantation Genetic Diagnostics (PGD) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preimplantation Genetic Diagnostics (PGD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preimplantation Genetic Diagnostics (PGD) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preimplantation Genetic Diagnostics (PGD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preimplantation Genetic Diagnostics (PGD) market.

Global Preimplantation Genetic Diagnostics (PGD) Scope and Market Size
Preimplantation Genetic Diagnostics (PGD) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preimplantation Genetic Diagnostics (PGD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis

Segment by Application
Fertility Clinics
Academic Medical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Cooper Surgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Beijing Genomics Institute (BGI)
Genea Limited
Hamilton Thorne
FUJIFILM Irvine Scientific
Nidacon International
Vitrolife AB
Merck
INVO Bioscience
IVFtech
Gonagen Medikal
Cook Medical
CellCura